MarketPulse

pharmaceutical R&D

5 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Delveinsight

Biosimulation Market to Hit $20B by 2034 as Drug Developers Embrace Virtual Trials

Global biosimulation market projected to expand from $4.7B in 2025 to $20B by 2034 at 17% CAGR, driven by regulatory support and virtual trial adoption.
DASTYSLPCERTSDGRdrug developmentprecision medicine
Investing.comInvesting.com··Jeffrey Neal Johnson

Lilly Bets $10B on AI and Neuroscience to Diversify Beyond GLP-1 Boom

Eli Lilly commits $10B to AI drug discovery partnership and sleep disorders acquisition, diversifying beyond its GLP-1 franchise.
LLYCNTArevenue diversificationartificial intelligence
GlobeNewswire Inc.GlobeNewswire Inc.··Sns Insider

Genomics Services Market Set to Triple to $25.18B by 2035 as Genetic Disorders Surge

Global genomics services market projected to grow from $7.94B in 2025 to $25.18B by 2035, driven by rising genetic disorder prevalence and precision medicine initiatives.
ILMNTMOLHDGXprecision medicinecompanion diagnostics
GlobeNewswire Inc.GlobeNewswire Inc.··Custom Market Insights

Microplate Systems Market to Double to $2.88B by 2035 on Biotech Boom

Global microplate systems market projected to grow from $1.42B (2025) to $2.88B (2035) at 10.7% CAGR, driven by pharma R&D spending and automation demand.
TMODHRGLWABIO+2automationmarket growth
GlobeNewswire Inc.GlobeNewswire Inc.··Researchandmarkets.Com

Alzheimer's Therapeutics Market Set to Exceed $6B by 2026 Amid Rising Investment

Alzheimer's therapeutics market projected to exceed $6B by 2026 driven by rising disease prevalence and increased pharma investment in disease-modifying treatments.
ABBVLLYNVORHHBYBIIBmarket growthAlzheimer's disease